Global Cancer (Tumor) Profiling Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Cancer (Tumor) Profiling market size was valued at USD 9533.2 million in 2023 and is forecast to a readjusted size of USD 19440 million by 2030 with a CAGR of 10.7% during review period.

Cancer(tumor) profiling is the technology oncologists use to determine if the pathways of a patient's tumor match up with available targeted treatments. Tumor profiling starts with obtaining a sample of tumor tissue. The tissue is usually collected through a core biopsy, but it can also be taken during surgery.

Surging cancer prevalence across the globe is one of the major factors contributing to the market growth. Cancer is the second leading cause of death worldwide. One in six deaths worldwide is due to cancer. In middle- and lower-class economies, 70% of deaths are due to cancer. This expands the growth scope of the market. Surging public-private funding of targeted research activities, emergence of cancer profiling relative to traditional methods of cancer diagnosis, increasing geriatric population base, and increasing product innovation and development due to technological advancements across the world will provide lucrative opportunities for market players. Estimated period 2022-2029. In addition, the surge in the number of strategic cooperations, rising Internet penetration, increasing number of hospitals and laboratories, increasing cases of lung cancer, prostate cancer, and acute leukemia, and increasing healthcare expenditure per capita will lead to further expansion of the market growth rate in the future.

The Global Info Research report includes an overview of the development of the Cancer (Tumor) Profiling industry chain, the market status of Clinical (Immunoassay, NGS), Research (Immunoassay, NGS), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer (Tumor) Profiling.

Regionally, the report analyzes the Cancer (Tumor) Profiling markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer (Tumor) Profiling market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cancer (Tumor) Profiling market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer (Tumor) Profiling industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunoassay, NGS).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer (Tumor) Profiling market.

Regional Analysis: The report involves examining the Cancer (Tumor) Profiling market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer (Tumor) Profiling market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cancer (Tumor) Profiling:
Company Analysis: Report covers individual Cancer (Tumor) Profiling players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer (Tumor) Profiling This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical, Research).

Technology Analysis: Report covers specific technologies relevant to Cancer (Tumor) Profiling. It assesses the current state, advancements, and potential future developments in Cancer (Tumor) Profiling areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer (Tumor) Profiling market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cancer (Tumor) Profiling market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Immunoassay
    NGS
    Mass Spectrometry
    Others

Market segment by Application
    Clinical
    Research

Market segment by players, this report covers
    Illumina
    Qiagen
    Neogenomics Laboratories
    HTG Molecular Diagnostics
    Genomic Health
    Caris Life Sciences
    Helomics Corporation
    Nanostring Technologies
    Oxford Gene Technology
    Ribomed Biotechnologies

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer (Tumor) Profiling product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer (Tumor) Profiling, with revenue, gross margin and global market share of Cancer (Tumor) Profiling from 2019 to 2024.
Chapter 3, the Cancer (Tumor) Profiling competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer (Tumor) Profiling market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer (Tumor) Profiling.
Chapter 13, to describe Cancer (Tumor) Profiling research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cancer (Tumor) Profiling
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cancer (Tumor) Profiling by Type
        1.3.1 Overview: Global Cancer (Tumor) Profiling Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Cancer (Tumor) Profiling Consumption Value Market Share by Type in 2023
        1.3.3 Immunoassay
        1.3.4 NGS
        1.3.5 Mass Spectrometry
        1.3.6 Others
    1.4 Global Cancer (Tumor) Profiling Market by Application
        1.4.1 Overview: Global Cancer (Tumor) Profiling Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Clinical
        1.4.3 Research
    1.5 Global Cancer (Tumor) Profiling Market Size & Forecast
    1.6 Global Cancer (Tumor) Profiling Market Size and Forecast by Region
        1.6.1 Global Cancer (Tumor) Profiling Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Cancer (Tumor) Profiling Market Size by Region, (2019-2030)
        1.6.3 North America Cancer (Tumor) Profiling Market Size and Prospect (2019-2030)
        1.6.4 Europe Cancer (Tumor) Profiling Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Cancer (Tumor) Profiling Market Size and Prospect (2019-2030)
        1.6.6 South America Cancer (Tumor) Profiling Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Cancer (Tumor) Profiling Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Illumina
        2.1.1 Illumina Details
        2.1.2 Illumina Major Business
        2.1.3 Illumina Cancer (Tumor) Profiling Product and Solutions
        2.1.4 Illumina Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Illumina Recent Developments and Future Plans
    2.2 Qiagen
        2.2.1 Qiagen Details
        2.2.2 Qiagen Major Business
        2.2.3 Qiagen Cancer (Tumor) Profiling Product and Solutions
        2.2.4 Qiagen Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Qiagen Recent Developments and Future Plans
    2.3 Neogenomics Laboratories
        2.3.1 Neogenomics Laboratories Details
        2.3.2 Neogenomics Laboratories Major Business
        2.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Product and Solutions
        2.3.4 Neogenomics Laboratories Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Neogenomics Laboratories Recent Developments and Future Plans
    2.4 HTG Molecular Diagnostics
        2.4.1 HTG Molecular Diagnostics Details
        2.4.2 HTG Molecular Diagnostics Major Business
        2.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Product and Solutions
        2.4.4 HTG Molecular Diagnostics Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 HTG Molecular Diagnostics Recent Developments and Future Plans
    2.5 Genomic Health
        2.5.1 Genomic Health Details
        2.5.2 Genomic Health Major Business
        2.5.3 Genomic Health Cancer (Tumor) Profiling Product and Solutions
        2.5.4 Genomic Health Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Genomic Health Recent Developments and Future Plans
    2.6 Caris Life Sciences
        2.6.1 Caris Life Sciences Details
        2.6.2 Caris Life Sciences Major Business
        2.6.3 Caris Life Sciences Cancer (Tumor) Profiling Product and Solutions
        2.6.4 Caris Life Sciences Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Caris Life Sciences Recent Developments and Future Plans
    2.7 Helomics Corporation
        2.7.1 Helomics Corporation Details
        2.7.2 Helomics Corporation Major Business
        2.7.3 Helomics Corporation Cancer (Tumor) Profiling Product and Solutions
        2.7.4 Helomics Corporation Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Helomics Corporation Recent Developments and Future Plans
    2.8 Nanostring Technologies
        2.8.1 Nanostring Technologies Details
        2.8.2 Nanostring Technologies Major Business
        2.8.3 Nanostring Technologies Cancer (Tumor) Profiling Product and Solutions
        2.8.4 Nanostring Technologies Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Nanostring Technologies Recent Developments and Future Plans
    2.9 Oxford Gene Technology
        2.9.1 Oxford Gene Technology Details
        2.9.2 Oxford Gene Technology Major Business
        2.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Product and Solutions
        2.9.4 Oxford Gene Technology Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Oxford Gene Technology Recent Developments and Future Plans
    2.10 Ribomed Biotechnologies
        2.10.1 Ribomed Biotechnologies Details
        2.10.2 Ribomed Biotechnologies Major Business
        2.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Product and Solutions
        2.10.4 Ribomed Biotechnologies Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Ribomed Biotechnologies Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cancer (Tumor) Profiling Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Cancer (Tumor) Profiling by Company Revenue
        3.2.2 Top 3 Cancer (Tumor) Profiling Players Market Share in 2023
        3.2.3 Top 6 Cancer (Tumor) Profiling Players Market Share in 2023
    3.3 Cancer (Tumor) Profiling Market: Overall Company Footprint Analysis
        3.3.1 Cancer (Tumor) Profiling Market: Region Footprint
        3.3.2 Cancer (Tumor) Profiling Market: Company Product Type Footprint
        3.3.3 Cancer (Tumor) Profiling Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cancer (Tumor) Profiling Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Cancer (Tumor) Profiling Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Cancer (Tumor) Profiling Consumption Value Market Share by Application (2019-2024)
    5.2 Global Cancer (Tumor) Profiling Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Cancer (Tumor) Profiling Consumption Value by Type (2019-2030)
    6.2 North America Cancer (Tumor) Profiling Consumption Value by Application (2019-2030)
    6.3 North America Cancer (Tumor) Profiling Market Size by Country
        6.3.1 North America Cancer (Tumor) Profiling Consumption Value by Country (2019-2030)
        6.3.2 United States Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        6.3.3 Canada Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        6.3.4 Mexico Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Cancer (Tumor) Profiling Consumption Value by Type (2019-2030)
    7.2 Europe Cancer (Tumor) Profiling Consumption Value by Application (2019-2030)
    7.3 Europe Cancer (Tumor) Profiling Market Size by Country
        7.3.1 Europe Cancer (Tumor) Profiling Consumption Value by Country (2019-2030)
        7.3.2 Germany Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        7.3.3 France Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        7.3.5 Russia Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        7.3.6 Italy Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Cancer (Tumor) Profiling Market Size by Region
        8.3.1 Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Region (2019-2030)
        8.3.2 China Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        8.3.3 Japan Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        8.3.4 South Korea Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        8.3.5 India Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        8.3.7 Australia Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Cancer (Tumor) Profiling Consumption Value by Type (2019-2030)
    9.2 South America Cancer (Tumor) Profiling Consumption Value by Application (2019-2030)
    9.3 South America Cancer (Tumor) Profiling Market Size by Country
        9.3.1 South America Cancer (Tumor) Profiling Consumption Value by Country (2019-2030)
        9.3.2 Brazil Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        9.3.3 Argentina Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Cancer (Tumor) Profiling Market Size by Country
        10.3.1 Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Country (2019-2030)
        10.3.2 Turkey Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
        10.3.4 UAE Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Cancer (Tumor) Profiling Market Drivers
    11.2 Cancer (Tumor) Profiling Market Restraints
    11.3 Cancer (Tumor) Profiling Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Cancer (Tumor) Profiling Industry Chain
    12.2 Cancer (Tumor) Profiling Upstream Analysis
    12.3 Cancer (Tumor) Profiling Midstream Analysis
    12.4 Cancer (Tumor) Profiling Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cancer (Tumor) Profiling Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Cancer (Tumor) Profiling Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Cancer (Tumor) Profiling Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Cancer (Tumor) Profiling Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Illumina Company Information, Head Office, and Major Competitors
    Table 6. Illumina Major Business
    Table 7. Illumina Cancer (Tumor) Profiling Product and Solutions
    Table 8. Illumina Cancer (Tumor) Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Illumina Recent Developments and Future Plans
    Table 10. Qiagen Company Information, Head Office, and Major Competitors
    Table 11. Qiagen Major Business
    Table 12. Qiagen Cancer (Tumor) Profiling Product and Solutions
    Table 13. Qiagen Cancer (Tumor) Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Qiagen Recent Developments and Future Plans
    Table 15. Neogenomics Laboratories Company Information, Head Office, and Major Competitors
    Table 16. Neogenomics Laboratories Major Business
    Table 17. Neogenomics Laboratories Cancer (Tumor) Profiling Product and Solutions
    Table 18. Neogenomics Laboratories Cancer (Tumor) Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Neogenomics Laboratories Recent Developments and Future Plans
    Table 20. HTG Molecular Diagnostics Company Information, Head Office, and Major Competitors
    Table 21. HTG Molecular Diagnostics Major Business
    Table 22. HTG Molecular Diagnostics Cancer (Tumor) Profiling Product and Solutions
    Table 23. HTG Molecular Diagnostics Cancer (Tumor) Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. HTG Molecular Diagnostics Recent Developments and Future Plans
    Table 25. Genomic Health Company Information, Head Office, and Major Competitors
    Table 26. Genomic Health Major Business
    Table 27. Genomic Health Cancer (Tumor) Profiling Product and Solutions
    Table 28. Genomic Health Cancer (Tumor) Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Genomic Health Recent Developments and Future Plans
    Table 30. Caris Life Sciences Company Information, Head Office, and Major Competitors
    Table 31. Caris Life Sciences Major Business
    Table 32. Caris Life Sciences Cancer (Tumor) Profiling Product and Solutions
    Table 33. Caris Life Sciences Cancer (Tumor) Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Caris Life Sciences Recent Developments and Future Plans
    Table 35. Helomics Corporation Company Information, Head Office, and Major Competitors
    Table 36. Helomics Corporation Major Business
    Table 37. Helomics Corporation Cancer (Tumor) Profiling Product and Solutions
    Table 38. Helomics Corporation Cancer (Tumor) Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Helomics Corporation Recent Developments and Future Plans
    Table 40. Nanostring Technologies Company Information, Head Office, and Major Competitors
    Table 41. Nanostring Technologies Major Business
    Table 42. Nanostring Technologies Cancer (Tumor) Profiling Product and Solutions
    Table 43. Nanostring Technologies Cancer (Tumor) Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Nanostring Technologies Recent Developments and Future Plans
    Table 45. Oxford Gene Technology Company Information, Head Office, and Major Competitors
    Table 46. Oxford Gene Technology Major Business
    Table 47. Oxford Gene Technology Cancer (Tumor) Profiling Product and Solutions
    Table 48. Oxford Gene Technology Cancer (Tumor) Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Oxford Gene Technology Recent Developments and Future Plans
    Table 50. Ribomed Biotechnologies Company Information, Head Office, and Major Competitors
    Table 51. Ribomed Biotechnologies Major Business
    Table 52. Ribomed Biotechnologies Cancer (Tumor) Profiling Product and Solutions
    Table 53. Ribomed Biotechnologies Cancer (Tumor) Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Ribomed Biotechnologies Recent Developments and Future Plans
    Table 55. Global Cancer (Tumor) Profiling Revenue (USD Million) by Players (2019-2024)
    Table 56. Global Cancer (Tumor) Profiling Revenue Share by Players (2019-2024)
    Table 57. Breakdown of Cancer (Tumor) Profiling by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Cancer (Tumor) Profiling, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 59. Head Office of Key Cancer (Tumor) Profiling Players
    Table 60. Cancer (Tumor) Profiling Market: Company Product Type Footprint
    Table 61. Cancer (Tumor) Profiling Market: Company Product Application Footprint
    Table 62. Cancer (Tumor) Profiling New Market Entrants and Barriers to Market Entry
    Table 63. Cancer (Tumor) Profiling Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Cancer (Tumor) Profiling Consumption Value (USD Million) by Type (2019-2024)
    Table 65. Global Cancer (Tumor) Profiling Consumption Value Share by Type (2019-2024)
    Table 66. Global Cancer (Tumor) Profiling Consumption Value Forecast by Type (2025-2030)
    Table 67. Global Cancer (Tumor) Profiling Consumption Value by Application (2019-2024)
    Table 68. Global Cancer (Tumor) Profiling Consumption Value Forecast by Application (2025-2030)
    Table 69. North America Cancer (Tumor) Profiling Consumption Value by Type (2019-2024) & (USD Million)
    Table 70. North America Cancer (Tumor) Profiling Consumption Value by Type (2025-2030) & (USD Million)
    Table 71. North America Cancer (Tumor) Profiling Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. North America Cancer (Tumor) Profiling Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. North America Cancer (Tumor) Profiling Consumption Value by Country (2019-2024) & (USD Million)
    Table 74. North America Cancer (Tumor) Profiling Consumption Value by Country (2025-2030) & (USD Million)
    Table 75. Europe Cancer (Tumor) Profiling Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Europe Cancer (Tumor) Profiling Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Europe Cancer (Tumor) Profiling Consumption Value by Application (2019-2024) & (USD Million)
    Table 78. Europe Cancer (Tumor) Profiling Consumption Value by Application (2025-2030) & (USD Million)
    Table 79. Europe Cancer (Tumor) Profiling Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Cancer (Tumor) Profiling Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Type (2019-2024) & (USD Million)
    Table 82. Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Type (2025-2030) & (USD Million)
    Table 83. Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Application (2019-2024) & (USD Million)
    Table 84. Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Application (2025-2030) & (USD Million)
    Table 85. Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Region (2019-2024) & (USD Million)
    Table 86. Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Region (2025-2030) & (USD Million)
    Table 87. South America Cancer (Tumor) Profiling Consumption Value by Type (2019-2024) & (USD Million)
    Table 88. South America Cancer (Tumor) Profiling Consumption Value by Type (2025-2030) & (USD Million)
    Table 89. South America Cancer (Tumor) Profiling Consumption Value by Application (2019-2024) & (USD Million)
    Table 90. South America Cancer (Tumor) Profiling Consumption Value by Application (2025-2030) & (USD Million)
    Table 91. South America Cancer (Tumor) Profiling Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. South America Cancer (Tumor) Profiling Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Type (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Type (2025-2030) & (USD Million)
    Table 95. Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Application (2019-2024) & (USD Million)
    Table 96. Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Application (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Country (2019-2024) & (USD Million)
    Table 98. Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Country (2025-2030) & (USD Million)
    Table 99. Cancer (Tumor) Profiling Raw Material
    Table 100. Key Suppliers of Cancer (Tumor) Profiling Raw Materials
List of Figures
    Figure 1. Cancer (Tumor) Profiling Picture
    Figure 2. Global Cancer (Tumor) Profiling Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Cancer (Tumor) Profiling Consumption Value Market Share by Type in 2023
    Figure 4. Immunoassay
    Figure 5. NGS
    Figure 6. Mass Spectrometry
    Figure 7. Others
    Figure 8. Global Cancer (Tumor) Profiling Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 9. Cancer (Tumor) Profiling Consumption Value Market Share by Application in 2023
    Figure 10. Clinical Picture
    Figure 11. Research Picture
    Figure 12. Global Cancer (Tumor) Profiling Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Cancer (Tumor) Profiling Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Market Cancer (Tumor) Profiling Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 15. Global Cancer (Tumor) Profiling Consumption Value Market Share by Region (2019-2030)
    Figure 16. Global Cancer (Tumor) Profiling Consumption Value Market Share by Region in 2023
    Figure 17. North America Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 18. Europe Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 19. Asia-Pacific Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 20. South America Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 21. Middle East and Africa Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 22. Global Cancer (Tumor) Profiling Revenue Share by Players in 2023
    Figure 23. Cancer (Tumor) Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 24. Global Top 3 Players Cancer (Tumor) Profiling Market Share in 2023
    Figure 25. Global Top 6 Players Cancer (Tumor) Profiling Market Share in 2023
    Figure 26. Global Cancer (Tumor) Profiling Consumption Value Share by Type (2019-2024)
    Figure 27. Global Cancer (Tumor) Profiling Market Share Forecast by Type (2025-2030)
    Figure 28. Global Cancer (Tumor) Profiling Consumption Value Share by Application (2019-2024)
    Figure 29. Global Cancer (Tumor) Profiling Market Share Forecast by Application (2025-2030)
    Figure 30. North America Cancer (Tumor) Profiling Consumption Value Market Share by Type (2019-2030)
    Figure 31. North America Cancer (Tumor) Profiling Consumption Value Market Share by Application (2019-2030)
    Figure 32. North America Cancer (Tumor) Profiling Consumption Value Market Share by Country (2019-2030)
    Figure 33. United States Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 34. Canada Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 35. Mexico Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 36. Europe Cancer (Tumor) Profiling Consumption Value Market Share by Type (2019-2030)
    Figure 37. Europe Cancer (Tumor) Profiling Consumption Value Market Share by Application (2019-2030)
    Figure 38. Europe Cancer (Tumor) Profiling Consumption Value Market Share by Country (2019-2030)
    Figure 39. Germany Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 40. France Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 41. United Kingdom Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 42. Russia Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 43. Italy Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 44. Asia-Pacific Cancer (Tumor) Profiling Consumption Value Market Share by Type (2019-2030)
    Figure 45. Asia-Pacific Cancer (Tumor) Profiling Consumption Value Market Share by Application (2019-2030)
    Figure 46. Asia-Pacific Cancer (Tumor) Profiling Consumption Value Market Share by Region (2019-2030)
    Figure 47. China Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 48. Japan Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 49. South Korea Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 50. India Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 51. Southeast Asia Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 52. Australia Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 53. South America Cancer (Tumor) Profiling Consumption Value Market Share by Type (2019-2030)
    Figure 54. South America Cancer (Tumor) Profiling Consumption Value Market Share by Application (2019-2030)
    Figure 55. South America Cancer (Tumor) Profiling Consumption Value Market Share by Country (2019-2030)
    Figure 56. Brazil Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 57. Argentina Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 58. Middle East and Africa Cancer (Tumor) Profiling Consumption Value Market Share by Type (2019-2030)
    Figure 59. Middle East and Africa Cancer (Tumor) Profiling Consumption Value Market Share by Application (2019-2030)
    Figure 60. Middle East and Africa Cancer (Tumor) Profiling Consumption Value Market Share by Country (2019-2030)
    Figure 61. Turkey Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 62. Saudi Arabia Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 63. UAE Cancer (Tumor) Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 64. Cancer (Tumor) Profiling Market Drivers
    Figure 65. Cancer (Tumor) Profiling Market Restraints
    Figure 66. Cancer (Tumor) Profiling Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Cancer (Tumor) Profiling in 2023
    Figure 69. Manufacturing Process Analysis of Cancer (Tumor) Profiling
    Figure 70. Cancer (Tumor) Profiling Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Companies Mentioned

Illumina
Qiagen
Neogenomics Laboratories
HTG Molecular Diagnostics
Genomic Health
Caris Life Sciences
Helomics Corporation
Nanostring Technologies
Oxford Gene Technology
Ribomed Biotechnologies